Purchase Order HHSN302201400128P

<p>The National Human Genome Research Institute awarded a purchase order to Roche Diagnostics Corporation for $5,940.00 on January 15, 2014, with final completion on February 15, 2014. Place of performance is North Bethesda, Maryland. The order is firm fixed price with no set-aside category. The specific scope of goods or services procured is not detailed in the source documentation.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Roche Diagnostics Corporation on May 5, 2015, with a ceiling value of $3,689.35 under firm fixed-price terms. Performance is located in North Bethesda, Maryland, with a completion date of June 5, 2015. The specific goods or services procured are not detailed in the source material.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Roche Diagnostics Corporation on February 19, 2016, with a ceiling value of $6,324.80 and firm fixed pricing. Performance is located in Bethesda, Maryland. The order was set to complete on December 23, 2020.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Roche Diagnostics Corporation valued at $18,452.94 on January 15, 2013, with ultimate completion on February 4, 2013. Place of performance is Castleton, Indiana. The order is firm fixed price with no set-aside designation.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $5,172.00 on August 2, 2017, for completion by September 1, 2017. Place of performance is North Bethesda, Maryland. The order is for firm fixed price commercial items, with no small business set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation on July 19, 2018, for $3,038.08, with an ultimate completion date of September 9, 2019. Work is performed in North Bethesda, Maryland. The order is a firm fixed price acquisition for commercial laboratory supplies or reagents supporting genomic research infrastructure. No small business set-aside applies.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Rees Scientific Corporation valued at $4,241.54 on August 9, 2016. Work is performed in Bethesda, Maryland. The order is firm fixed price with no small business set-aside. Ultimate completion is scheduled for December 23, 2020. The source does not specify the goods or services procured.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $18,816.00 on August 31, 2018, with ultimate completion on September 28, 2018. Place of performance is Bethesda, Maryland. The order is priced as firm fixed price with no set-aside used. The source does not specify the items or services procured.</p>

<p>The National Human Genome Research Institute awarded a purchase order to The Remi Group LLC for $54,931.33 on November 6, 2012, with an ultimate completion date of October 15, 2013.</p> <p>Work is performed in Bethesda, Maryland. The order procures equipment maintenance and technical support services for scientific instrumentation. Pricing is firm fixed price under full and open competition with no set-aside category.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $3,639.24 on September 26, 2017, with completion by October 18, 2017. Performance occurs in Bethesda, Maryland. The order provides laboratory instrumentation, reagents, or consumables; specific line items are not detailed in the award record. Pricing is firm fixed price with no set-aside applied.</p>